Julie Lea Lipszyc, Quality Lead/Engineering Services, Therapure Biopharma Inc. September 2015

Similar documents
QUALITY RISK MANAGEMENT (QRM): A REVIEW

Quality Risk Management The Pharmaceutical Experience Ann O Mahony Quality Assurance Specialist Pfizer Biotech Grange Castle

Quality Risk Management

Guidance for Industry

QUALITY RISK MANAGEMENT

Best Practice In A Change Management System

Quality Risk Management Tools Quality Risk Management Tool Selection When to Select FMEA: QRM Tool Selection Matrix

Quality Risk Management Understanding and Control the Risk in Pharmaceutical Manufacturing Industry

Quality Assurance. Disclosure for Lilli Møller Andersen. No relevant financial relationships exist for any issue mentioned in this presentation

Quality Risk Management ICH Q9 & ISO Presented by Michael Kerr 11 th November 2011

QA GLP audits. Alain Piton. Antipolis,, France.

The use of risk assessment tools for microbiological assessment of cleanroom environments. by Tim Sandle

Media fills Periodic performance qualification (Re-Validation)

Combination Products. Presented by: Karen S. Ginsbury For: IFF March PCI Pharma

ICH Q9 Quality Risk Management - an industry view. Peter H. Gough, Eli Lilly and Company

Guidance for Industry: Quality Risk Management

Annex 2. WHO guidelines on quality risk management. 1. Introduction Glossary Quality risk management process 70

FOOD SAFETY MANAGEMENT SYSTEMS (FSMS): REQUIREMENTS FOR ANY ORGANISATION IN THE FOOD CHAIN (ISO 22000:2005)

Title:: Effective GMP AUDITS for APIs and Formulation Pharma Companies By G.Sundar-Director/Consultant PharmQA Compliance solutions

EudraLex. The Rules Governing Medicinal Products in the European Union Volume 4

Risk Assessment for Medical Devices. Linda Braddon, Ph.D. Bring your medical device to market faster 1

The FDA recently announced a significant

Risk Management for Aseptic Processing

Annex 7 Guidelines on pre-approval inspections

Quality Risk Management in Pharmaceutical Industry: A Review

Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations

CONCEPTS OF FOOD SAFETY QUALITY MANAGEMENT SYSTEMS. Mrs. Malini Rajendran

cgmp Challenges for Cord Blood Banks

Risk-Based Environmental Monitoring. Marsha Stabler Hardiman Senior Consultant Concordia ValSource Wednesday September 17, 2014 FDA/PQRI

Application of Quality Risk Management to Pharmaceutical Operations. Eldon Henson, Vice President, Quality Operations

Conducting a Gap Analysis on your Change Control System. Presented By Miguel Montalvo, President, Expert Validation Consulting, Inc.

The purpose of this Supplier Quality Standard is to communicate the expectations and requirements of Baxter Healthcare Corporation to its suppliers.

Quality Risk Management Principles and Industry Case Studies

Leila Kakko Tampere University of Applied science TRADITIONAL FOOD IN COMBATING FOODBORNE PATHOGENS 2011

Cleaning Validation in Active pharmaceutical Ingredient manufacturing plants

Risk Assessment and Management. Allen L. Burgenson Manager, Regulatory Affairs Lonza Walkersville Inc.

Background on QRM. Pharma EXPO September 2015 Las Vegas, NV. Your QRM Program. Paul H. Ahlijanian

ICH guideline Q10 on pharmaceutical quality system

Hazard Analysis and Critical Control Points (HACCP) 1 Overview

Library Guide: Pharmaceutical GMPs

Deviation Handling and Quality Risk Management

Annex 7 Application of Hazard Analysis and Critical Control Point (HACCP) methodology to pharmaceuticals

LIBRARY GUIDE. Online Courses. March 2012

Risk-Based Validation of Commercial Off-the-Shelf Computer Systems

Improved Utilization of Self-Inspection Programs within the GMP Environment A Quality Risk Management Approach

Preparing for the Pre-Approval Inspection What to do Before the FDA Arrives. Barry A. Friedman, Ph.D. Consultant

PHARMACEUTICAL QUALITY SYSTEM Q10

3.0 Risk Assessment and Analysis Techniques and Tools

FDA and the Compounding Pharmacy

TSI BIOTRAK REAL-TIME VIABLE PARTICLE COUNTER FACILITY MONITORING SYSTEMS

Design Verification The Case for Verification, Not Validation

Controlling Risks Risk Assessment

Microbiology and Auditing. Don Singer

BRC Food Safety and Quality Management System. New Issue 7

ICH Q10 - Pharmaceutical Quality System

Cleaning and Contamination Control

Guidance on Qualification of existing facilities, systems, equipment and utilities

Edwin Lindsay Principal Consultant. Compliance Solutions (Life Sciences) Ltd, Tel: + 44 (0) elindsay@blueyonder.co.

Impact Assessment in a Science & Risk Based Environment. R. Legland 11/04/11

Recent Updates on European Requirements and what QPs are expected to do

Risk Assessment Tools for Identifying Hazards and Evaluating Risks Associated with IVD Assays

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex. The Rules Governing Medicinal Products in the European Union

Risk assessment is used as a

Guidance for Industry. Q10 Pharmaceutical Quality System

GMP ANNEX 1 REVISION 2008, INTERPRETATION OF MOST IMPORTANT CHANGES FOR THE MANUFACTURE OF STERILE MEDICINAL PRODUCTS

Comparative analysis between the possible regulatory approaches to GMP compliance TITOLO PRESENTAZIONE

Design, Operation and Management of GTP/GMP Cell Engineering Facilities

Harmonizing Change Control Processes Globally

New Guidelines on Good Distribution Practice of Medicinal Products for Human Use (2013/C 68/01)

Optimizing Quality Control / Quality Assurance Agents of a Global Sourcing / Procurement Strategy

GRADUATE CERTIFICATE IN GOOD MANUFACTURING PRACTICE (GMP) Plan your career for tomorrow and you will be ahead of your competitors

Development and Validation of In Vitro Diagnostic Tests. YC Lee, Ph.D. CEO

PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7: NON-STERILE PROCESS VALIDATION

1

Canadian Pharmaceutical GMP

CONTROL PLANS IN FOOD SAFETY MANAGEMENT SYSTEMS

Pharmaceutical Quality Systems: US Perspective

Principles. of Pharmaceutical Facility Design. Full Time Part Time Online.

PROPOSED UPDATED TEXT FOR WHO GOOD MANUFACTURING PRACTICES FOR PHARMACEUTICAL PRODUCTS: MAIN PRINCIPLES (JANUARY 2013)

ASSESSMENT OF QUALITY RISK MANAGEMENT IMPLEMENTATION

World Health Organization Prequalification of Medicines

Cleanroom. For. Sterile Manufacturing Facilities

Standard Operating Procedure Title: Quality Risk Management Techniques

MHRA GMP Data Integrity Definitions and Guidance for Industry January 2015

Working Party on Control of Medicines and Inspections. Final Version of Annex 15 to the EU Guide to Good Manufacturing Practice

GLP vs GMP vs GCP Dominique Pifat, Ph.D., MBA The Biologics Consulting Group

ASI 691 Prinicples of HACCP 1

Manufacturing Cellular Products for International Clinical Trials

11.I In-process control Authors: Dr. Christian Gausepohl / Paolomi Mukherji / Update 07

Extemporaneously Prepared Early Phase Clinical Trial Materials

Auditing as a Component of a Pharmaceutical Quality System

MHRA GMP Data Integrity Definitions and Guidance for Industry March 2015

SPECIFICATIONS AND CONTROL TESTS ON THE FINISHED PRODUCT

INTRODUCTION. This book offers a systematic, ten-step approach, from the decision to validate to

On-Site GMP Training GMP COMPLIANCE TECHNICAL

Food Safety and Quality Management System

UNICEF s Quality Assurance System for Procurement of Micronutrient Powders (MNP)

RC-17. Alejandro V. Nader National Regulatory Authority Montevideo - Uruguay

Implementing New USP Chapters for Analytical Method Validation

Workflow System for Paperless Air Monitoring Powered by MODA. Presented by

Transcription:

Compliance Risk Assessment in Capital Expansion Projects Julie Lea Lipszyc, Quality Lead/Engineering Services, Therapure Biopharma Inc. September 2015

Share an applied and practical approach to perform quality / compliance risk assessment during engineering / capital expansion projects Share Engineering / capital expansion projects Practical Approach Quality / Compliance risk assessment 2

What are we going to talk about? What is a Risk? Why doing risk assessment from a regulatory perspective? What is a quality/compliance risk assessment? Some GMP requirements related to cross contamination & mixups When to do quality/compliance risk assessment during capital expansion projects? Who should be part of the risk assessment exercise? Approach, Tools & Methodology Typical QRM Developed Excel Tool Report Mitigation implementation/risk review 3

Risk is Quality Risk Management (QRM) is Combination of probability of occurrence of harm, and severity of that harm Process that helps Identify risks Analyse them and then Create an action plan to remediate / mitigate the risks Fact: No process is risk free 4

Why doing Risk Assessment from a regulatory perspective? FDA (1/2) US FDA Quality System Regulation : Request to validate design of medical devices and design validation should include risk analysis (as appropriate) Risk based compliance : important element of the FDA's Pharmaceutical cgmp Initiative for the 21st Century (2002) Guidance for Industry Quality Systems Approach to Pharmaceutical CGMP Regulations This guidance is intended to help manufacturers implementing modern quality systems and risk management approaches to meet the requirements of the Agency's CGMP regulations 5

Why doing Risk Assessment from a regulatory perspective? FDA (2/2) Guidance for Industry Quality Systems Approach to Pharmaceutical CGMP Regulation (cont.) 6 Quality Risk Management: Effective decision making in a quality systems environment is based on an informed understanding of quality issues. It is important to engage appropriate parties in assessing the risk Implementation of quality risk management includes assessing the risks, selecting and implementing risk management controls commensurate with the level of risk, and evaluating the results of the risk ikmanagement efforts. Since risk ik management is an iterative process, it should be repeated if new information is developed that changes the need for, or nature of, risk management..

Why doing Risk Assessment from a regulatory perspective? EU (1/2) Eudralex Volume 4 EU GMP Chapter 1 1.12 Quality risk management is a systematic process for the assessment, control, communication and review of risks to the quality of the medicinal product. 1.13 The principles of quality risk management are that: i) The evaluation of the risk to quality is based on scientific knowledge, experience with the process and ultimately links to the protection of the patient ii) The level of effort, formality and documentation of the quality risk management process is commensurate with the level of risk. 7

Why doing Risk Assessment from a regulatory perspective? EU (2/2) Eudralex Vl Volume 4 EU GMP Chapter 5 A Quality Risk Management process should be used to assess and control the cross contamination risks presented by the products manufactured. Factors including; facility/equipment design and use, personnel and material flow, microbiological controls, physico chemical characteristics of the active substance, process characteristics, cleaning processes and analytical capabilities relative to the relevant limits established from the evaluation of the products should also be taken into account The outcome of the Quality Risk Management process should ldbe the basis for determining the extent of technical and organisational measures required to control risks for cross contamination. 8

Why doing Risk Assessment from a regulatory perspective? ICH Single most important document about risk management: ICHQ9 Guide on Quality Risk Management Describes a systematic approach for risk management I It s THE QRM guide! 9

Regulatory Focus on Sound Risk Assessments 10 Equivalent information mentioned in EudraGMP inspection findings

Ok, Risk assessment is needed but which kind? 11 Basic risk management facilitation methods (Flow charts) Failure Mode Effects Analysis (FMEA) Failure Mode, Effects and Criticality Analysis (FMECA) Fault Tree Analysis (FTA) Hazard Analysis and Critical Control Points (HACCP) Hazard Operability Analysis (HAZOP) Preliminary i Hazard danalysis (PHA) Risk Ranking and Filtering GAMP Kepner Tregoe (KT) Analysis SLIA CLIA What If

Quality / Compliance risk assessment what whatis it? FMEA Failure Mode and Effects Analysis Brainstorms potentialfailure Based on P&ID or operating procedure review Examination of ways that equipment can fail and how each failure affects process Quality & Compliance risk assessment To identify risks related to Microbiological i l contamination i Contamination/mix ups by other products/personnel/material Airborne Contamination Order of activities Layout and equipment design 12

Quality / Compliance risk assessment what whatis it? Mainly review of Equipment designs Layouts Flows (personnel, material (raw material and clean and dirty equipment), waste, product) PFDs Review of project design versus plant current practices 13

Some GMP Requirements related to cross contamination & mixups 14

Crosscontamination & mixups USFDA 21 CFR 211.42(b):" Any such building shall llhave adequate space for the orderly placement of equipment and materials to prevent mixups between different components, drug product containers, closures, labeling, in process materials, or drug products, and to prevent contamination. The flow of components, drug product containers, closures, labeling, in process materials, and drug products through the building or buildings shall be designed to prevent contamination." 21 CFR 211.42(c):"Operations shall be performed within specifically defined areas of adequate size. There shall be separate or defined areas orsuch other control systems for the firm's operations as are necessary to prevent contamination or mixups during the course of the following procedures. 15

Crosscontamination & mixups US USFDA 21 CFR 211.67(a): Equipment and utensils shall be cleaned, maintained, and sanitized at appropriate intervals to prevent malfunctions or contamination that would alter the safety, identify, strength, quality, or purity of the drug product beyond the official or other established requirements. FDA Guidance for Industry Sterile Drug Products Produced by Aseptic Processing Current Good Manufacturing Practice Both personnel and material flow should be optimized to prevent unnecessary activities that could increase the potential for introducing contaminants to exposed product, container closures, or the surrounding environment. It is critical to adequately control material (e.g., in process supplies, equipment, utensils) as it transfers from lesser to higher classified clean areas to prevent the influx of contaminants. 16

Cross contamination & mixups EU GMP Volume 4 EU guidelines GMP Chapter 3 Premises i and equipment must be located, designed, d constructed t to suit the operations to be carried out. Their layout and design must aim to minimise the risk of errors to avoid crosscontamination... Cross contamination should be prevented for all products by appropriate design and operation of manufacturing... The adequacy of the working and in process storage space should permit the orderly and logical positioning of equipment and materials so as to minimise the risk of confusion between different medicinal products or their components, to avoid cross contamination Volume 4 EU guidelines GMP Chapter 5 Operations on different products should not be carried out simultaneously or consecutively in the same room unless there is no risk of mix up or cross contamination 17

Cross contamination & mixups EU GMP Volume 4 EU guidelines GMP Chapter 5 Contamination of a starting material or of a product by another material or product should be prevented. This risk of accidental cross contamination should be assessed Volume 4 EU guidelines GMP Annex 2 Biological active substances: Manufacturing and storage facilities, processes and environmental classifications should be designed to prevent the extraneous contamination of products... Air handling units should be designed, constructed and maintained to minimise the risk of cross contamination between different manufacturing areas and may need to be specific for an area Equipment used during handling of live organisms and cells, including those for sampling, should be designed to prevent any contamination during processing 18

Compliance risk assessment when to do it during capital expansion projects? 1. Start during detailed design 2. Issue first version early during construction or at the latest at the beginning of installation 3. Review (new version) after 1st engineering run to document implementation ofremediation actions andassessassess new potential risks 19

Whoshould be part of the risk assessmentexercise? exercise? Output only as good as the input most important : inputs should not only come from single individuals but from a risk management team Subject mater experts (SME) are the key 20

Whoshould be part of the risk assessmentexercise? exercise? Cross functional team composed of Engineering project SME Designers project SME Facility/Maintenance project SME Future Users (Production) Validation project SME Quality project SME (usually y the leader of the exercise) ) 21

Use Microsoft Word or Excel templates / forms Filled out by risk management team members Valuable tool to improve consistency and efficiency Make the entire risk management process efficient and consistent Approach, Tools & Methodology 22

Typical QRM process Initiate Quality Risk Management Process Risk Assessment Risk Identification Risk Communication Risk Control Risk Analysis Risk Evaluation Risk Reduction Risk Acceptance unacceptable Risk Management tools Compliance risk assessment Excel table (risk identification, analysis, proposal of mitigation measures for risk control) Output / Result of the Quality Risk Management Process Compliance risk assessment report Risk Review Review Events Review/update of risk assessment table and report, review for implementation evidences of mitigation solutions and new potential risks 23

Developed Excel Tool 24

Process Parameter Version Process Parameter : location where the risk is identified Flow (ex. material, personnel, waste, etc.) Room (room number) Process area (ex. pre viral/production, formulation, fill finish, i buffer preparation area, wash up area, etc.) 25

Risk Identification Description of the risk Risk Type (ex. cross contamination, mix ups, product integrity, reconciliation, process control, room control, etc.) = Categorisation of the risk allowing grouping and analysis 26

Identify Risks During brainstorming meeting Review and compare each other Retain only credible risks Do not put a risk in the list if controls are currently in place to reduce the risk to an acceptable level and no additional action is required (i.e. the project does not add any new risk to current practices) Leave in the list only risks without sufficient control 27

Risk Analysis For each risk, establish Severity severity of risk on product quality Probability of occurrence likelihood of the risk to occur Detectability likelihood lih that the risk ikwill be noted before bf harm occurs 28

For each risk identified, analyze Severity (S) severity of risk ikon product quality (1 high, 2 medium, 3 low) Probability of occurrence (P) likelihood of the risk to occur (1 often, 2 occasionally, 3 rarely) Intersection of Severity and Probability = Risk Level 29

Qualitative or semi quantitative rating Rating can be qualitative, quantitative or semi quantitative Unless thorough statistical or other reliable data available, scales = qualitative Ex. qualitative: 'high', 'medium' or 'low Equivalent semi quantitative: 'once a day', 'once a week' or 'once a month'. Ex. qualitative & semi quantitative descriptions for severity Qualitative Semi Quantitative Quantitative 30 Very high Frequent / Likely to happen Every day High Probable Every 3 days Medium Occasionally Every week Low Can happen Every 3 weeks Very low Improbable Every 2 months

Risk evaluation Detectability (D) likelihood that the risk will be noted before harm occurs (1 low, 2 medium, 3 high) Risk Remediation Priority Intersection of Risk Level and Detectability 31

Risk Control Decision to mitigate/remediate/control or accept the risk Priority of risk resolution: When everything is a priority, nothing is a priority! 32

Risk control Risk Remediation Priority Intersection of Risk Level and Detectability Risk Remediation Priority: High (red) Risk: Primary risk to be mitigated Unacceptable risk, must be mitigated Medium (white) Risk: Risk should be mitigated Second priority Low (green) Risk: Risk acceptable (risk threshold) Could be mitigated (third priority) 33

Risk Control Decision i Mki Making Risk reduction / mitigation? or Risk acceptance? Risk reduction Actions taken to lessen the probability of occurrence of risk and the severity of the risk: mitigationsolutions Typically validation activities, engineering studies, SOP/batch production records modifications, design measures Risk acceptance Decision to accept the risk 34 34

Risk control Basis for Judgment Is the risk above the acceptable level? What can done to reduce or eliminate risks? What is the appropriate balance among benefits, risks and resources? Are new risks introduced as a result of the identified risks being controlled? 35

Risk Mitigation Mitigation solutions (list of solutions to mitigate risks) Several solutions may be required to mitigate one risk Mitigation solution type (categorization of mitigation solutions proposed: SOP, batch production records, validation, engineering study, process controls, etc.) Action Required (more detailed action required to implement the mitigation solution) Mitigation status (not yet mitigated, partially mitigated, mitigated) Remaining actions (actions to implement to mitigate the risk) 36

Risk Mitigation Different ways & approaches to mitigate t risks ik Removing the risk source (eliminating the risk) Changing the likelihood (occurrence) Changing the consequences (severity) Ensuring that the risk is detected and can be treated when it occurs (detectability) All risk mitigation options should be considered and can be combined Mitigation ofone one risk to anacceptableacceptable level may createnew other acceptable or unacceptable risks (to mitigate too) or increase existing risks in other areas. Care needs to be taken when identifying mitigation solutions 37

Cross Contamination Contamination Risk Reduction Examples From Mix up Redundant electronic verification of materials Redundant manual checks Color coding Bar coding and RFID of materials & equipment Locked cages to store APIs with chain of custody Process Analytical Technologies Separate dispensing areas Separate raw material staging areas Segregate flows From Mechanical/Airborne Transfer Limit transfer of compounds between suites ie. High Shear Granulation, Milling, and Drying in same suite Segregate work areas to a single product Contain at the Source Close process systems Room airflow Airlock separation to corridor Room differential pressures Gowning procedures Wipe down/decontamination protocols for mobile equipment Cleaning bays with dirty / clean pass throughh 38

Report Critical part of the results of the Risk Assessment : The Report! Provide confidence that risks identified are /will be controlled / mitigated / remediated 39

Report content Report approval Responsibility Scope and purpose Process description Process flow diagram (PFD) / Project production room layout Facility design information Quality system procedures Shared equipment, utilities and production areas Risk assessment methodology and procedure Results & conclusion (graphical analysis of the type of risks identified, their level (remediation priority), their mitigation solutions and mitigation status) Glossary and acronyms 40

Graphical analysis List of rooms/areas where no specific project risks were identified % of risks identified per area Number & Type of Risks per area Type / Categories of Identified Risks Levels of risks identified Categories of risks per risk level Mitigation status per risk levels & categories Mitigation solutions type Risks mitigation solutions 41

Mitigation implementation/risk Review Follow up of implementation (evidence) of solutions Identification of new risks Confirmation mitigation measures are in place AND sufficient to reduce risk to acceptable level "Review or monitoring of output/results of the risk management process considering (if appropriate) new knowledge and experience about the risk." (ICH Q9)

Summary 43 Quality & compliance risk assessment : not an enhanced design review. Regulatory agencies expect to demonstrate using scientifically sound assessment how to prevent cross contamination and to justify the level of controls Piece of advice to perform good risk assessment: do not mix everything together: compliance, hazard analysis, failure analysis Risk becomes : never finish the risk assessment exercise. Do not find risk everywhere and for everything Goal: Identify and mitigate credible and real risks Tool to bridge regulatory/qa/validation focus with engineering/capex: share knowledge, mitigate risks of non compliance

Thank you! 44

Julie Lea Lipszyc, Quality Lead/Engineering Services Master s Degree Quality Assurance of pharmaceutical, cosmetic and dietetic products (Paris, France) ~ 20 years in pharmaceutical, biotech and medical devices sectors: Compliance design reviews Risk assessments Quality systems design and implementation Quality assurance team management Regulatory affairs Cleaning & microbiological method validation Compliance & validation project management Qualification / validation Field of expertise : Canadian, US and European regulations APIs High potency compounds Drugs Laboratories Blood and tissue products Clinical trials 45 Biotech (vaccines) Sterile products Medical devices Natural health products